​

Acurx Pharmaceuticals Ownership | Who Owns Acurx Pharmaceuticals?


OverviewFinancialsChartTranscripts

Acurx Pharmaceuticals Ownership Summary


Acurx Pharmaceuticals is owned by 4.22% institutional investors, 2.12% insiders, and 93.65% retail investors. Vanguard capital management is the largest institutional shareholder, holding 0.73% of ACXP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.97% of its assets in Acurx Pharmaceuticals shares.

ACXP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAcurx Pharmaceuticals4.22%2.12%93.65%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard capital management31.10K0.73%$39.19K
Geode capital management26.30K0.62%$33.13K
Vanguard fiduciary trust16.20K0.38%$20.42K
Nbc securities15.20K0.36%$19.15K
Cambridge investment research advisors15.00K0.35%$19.00K
Prospect financial services13.29K0.31%$16.74K
Jane street group12.96K0.30%$16.33K
Susquehanna group, llp48.37K0.30%$39.38K
Hrt financial lp10.01K0.23%$12.00K
Blackrock27.50K0.18%$61.88K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prospect financial services13.29K0.01%$16.74K
Semmax financial advisors5.88K0.00%$11.17K
Nbc securities15.20K0.00%$19.15K
Westside investment management1.65K0.00%$2.08K
Tower research capital llc (trc)1.03K0.00%$3.83K
Blackrock27.50K-$61.88K
Renaissance---
Geode capital management26.30K-$33.13K
Act advisors, llc.---
Wealthcare advisory partners---

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp48.37K-48.37K
Cambridge investment research advisors15.00K-15.00K
Nbc securities15.20K0.00%13.70K
Hrt financial lp10.01K-10.01K
Blackrock27.50K-8.81K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.08M
Vanguard group---145.54K
Renaissance---87.78K
Sabby management---81.89K
O'brien greene---60.00K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp48.37K-48.37K$39.38K
Hrt financial lp10.01K-10.01K$12.00K

Sold Out

HolderChange
Citigroup-1.00
Jpmorgan chase-29.00
Advisory services network-59.00
Cornerstone planning group-167.00
Barclays-281.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202618-5.26%179,86044.60%449.52%620.00%525.00%
Jun 30, 202619-13.64%124,385-32.10%21.96%5-54.55%4-
Mar 31, 20262116.67%181,86131.20%67.82%10-4-20.00%
Dec 31, 20251812.50%138,609119.55%961.32%10150.00%5-58.33%
Sep 30, 20251-96.67%7,582-99.70%-0.58%--100.00%1-85.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF384.36K1.97%551.00
Vanguard Total Stock Mkt Idx Inv383.81K1.63%-
Vanguard Institutional Extnd Mkt Idx Tr31.10K0.66%-
Fidelity Extended Market Index21.25K0.39%-
iShares Micro-Cap ETF27.76K0.12%-
NT Ext Equity Mkt Idx Fd - L2.77K0.10%-13.73K
Spartan Extended Market Index Pool E15.76K0.08%650.00
Spartan Extended Market Index Pool F3.38K0.08%-
Northern Trust Extended Eq Market Idx2.77K0.06%-
NT Ext Equity Mkt Index Fund - Lending2.77K0.06%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2025Scodari Joseph C-Buy$25.00K
Jan 06, 2025Scodari Joseph C-Buy$22.17K
Jan 06, 2025Sailer Carl-Buy$25.00K
Jan 06, 2025Sailer Carl-Buy$22.17K
Jan 06, 2025LUCI DAVID P President and CEOBuy$50.00K

Insider Transactions Trends


DateBuySell
2026 Q2--
2025 Q112-
2024 Q2--
2024 Q1--
2023 Q4--

ACXP Ownership FAQ


Who Owns Acurx Pharmaceuticals?

Acurx Pharmaceuticals shareholders are primarily institutional investors at 4.22%, followed by 2.12% insiders and 93.66% retail investors. The average institutional ownership in Acurx Pharmaceuticals's industry, Biotech Stocks , is 181.71%, which Acurx Pharmaceuticals falls below.

Who owns the most shares of Acurx Pharmaceuticals?

Acurx Pharmaceuticals’s largest shareholders are Vanguard capital management (31.1K shares, 0.73%), Geode capital management (26.3K shares, 0.62%), and Vanguard fiduciary trust (16.2K shares, 0.38%). Together, they hold 1.73% of Acurx Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acurx Pharmaceuticals?

Yes, BlackRock owns 0.18% of Acurx Pharmaceuticals, totaling 27.5K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 61.88K$. In the last quarter, BlackRock increased its holdings by 8.82K shares, a 47.17% change.

Who is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Prospect financial services is Acurx Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 13.28K Acurx Pharmaceuticals shares, valued at 16.74K$.

Who is the top mutual fund holder of Acurx Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Acurx Pharmaceuticals shares, with 1.97% of its total shares outstanding invested in 384.36K Acurx Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools